Viewing Study NCT01527032


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2025-12-30 @ 4:02 PM
Study NCT ID: NCT01527032
Status: COMPLETED
Last Update Posted: 2015-03-25
First Post: 2011-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Risk-adapted Therapy for Primary Systemic (AL) Amyloidosis
Sponsor: FDA Office of Orphan Products Development
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module